Stifel Financial
ANIK icon

Stifel Financial’s Anika Therapeutics ANIK Stock Holding History

Stifel Financial’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-53,316
Closed -$2.41M – 3204
2020
Q4 		$2.41M Sell
53,316
-887
-2% -$33.7K ﹤0.01% 1275
2020
Q3 		$1.92M Sell
54,203
-1,453
-3% -$52.5K ﹤0.01% 1234
2020
Q2 		$2.1M Sell
55,656
-761
-1% -$25.1K ﹤0.01% 1126
2020
Q1 		$1.65M Sell
56,417
-19,725
-26% -$798K ﹤0.01% 1143
2019
Q4 		$3.96M Sell
76,142
-17,133
-18% -$995K 0.01% 983
2019
Q3 		$5.11M Sell
93,275
-5,345
-5% -$274K 0.01% 818
2019
Q2 		$4.01M Buy
98,620
+44,510
+82% +$1.62M 0.01% 953
2019
Q1 		$1.64M Buy
54,110
+5,035
+10% +$172K ﹤0.01% 1356
2018
Q4 		$1.65M Sell
49,075
-286
-0.6% -$10.3K 0.01% 1255
2018
Q3 		$2.09M Sell
49,361
-144,806
-75% -$5.72M 0.01% 1241
2018
Q2 		$6.17M Sell
194,167
-64,709
-25% -$2.67M 0.02% 717
2018
Q1 		$12.9M Buy
258,876
+74,311
+40% +$4.2M 0.04% 437
2017
Q4 		$9.96M Buy
184,565
+4,998
+3% +$277K 0.03% 530
2017
Q3 		$10.5M Buy
179,567
+15,873
+10% +$830K 0.04% 491
2017
Q2 		$8.08M Buy
163,694
+22,990
+16% +$1.06M 0.03% 557
2017
Q1 		$6.12M Buy
140,704
+127,109
+935% +$6.07M 0.02% 624
2016
Q4 		$662K Buy
13,595
+2,178
+19% +$101K ﹤0.01% 1620
2016
Q3 		$548K Buy
11,417
+605
+6% +$29.9K ﹤0.01% 1680
2016
Q2 		$581K Buy
10,812
+520
+5% +$24.5K ﹤0.01% 1671
2016
Q1 		$461K Buy
10,292
+1,343
+15% +$54.5K ﹤0.01% 1624
2015
Q4 		$341K Buy
8,949
+544
+6% +$20.8K ﹤0.01% 1842
2015
Q3 		$267K Buy
+8,405
New +$293K ﹤0.01% 1879

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Stifel Financial's ANIK Position: Q1 2021 in Review

Stifel Financial sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 53,316 shares — an estimated $2.41M sold.

Stifel Financial first reported a position in ANIK in Q3 2015 and held it in 22 quarters. The position peaked at $12.9M in Q1 2018. 145 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • Stifel Financial reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Stifel Financial sold 53,316 Anika Therapeutics shares in Q1 2021, an estimated $2.41M.
  • Stifel Financial first reported a position in Anika Therapeutics in Q3 2015 and held it in 22 quarters.
  • Stifel Financial's Anika Therapeutics position peaked at $12.9M in Q1 2018.
  • 145 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on Stifel Financial's 13F filing for Q1 2021, filed 14 May 2021.